News
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...
Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...
The Food and Drug Administration (FDA) will require more evidence for what top officials describe as the uniquely American ...
FDA outlines new COVID-19 vaccine regulations, requiring randomized trials when approving shots for healthy Americans. Read ...
Agency will ask drugmakers for large trials for new versions of vaccines meant for healthy adults and children.
46mon MSN
The U.S. Food and Drug Administration is changing the way it approves COVID-19 vaccines for Americans — a move that will ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
The requirement for placebo-controlled trials isn’t expected to affect the rollout this fall for older adults and other groups at high risk for severe illness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results